Monday 5 December 2016

Home Infusion Therapy - Administration of Medications through Needles and Catheters

Infusion therapy refers to the administration of medications through needles and catheters. These procedures are usually performed when oral medication treatments are not effective on the patients. Home infusion therapies are those infusion therapies that can be taken by the patient at home, upon prescription by a physician. Home infusion therapies are taken either through intravenous (IV) routes into the bloodstream or a tube placed in the patient’s intestine or stomach.

Various drug therapies are performed at home including pain management, parenteral nutrition, antibiotics and IVIG therapy. In addition, insulin home infusion therapy is also performed; it is the most widely used home infusion therapy. Pain killers and IVIG account for the major market shares after insulin. IVIG can be allowed to be administered to a patient after the diagnosis of congestive heart failure, neurological disorders and immune disorders. Home infusion therapy requires administrative services, pharmacy services, patient educating and training, equipments, care coordination and supplies.

Change in lifestyle will boost the growth of home infusion therapy market. In addition, increase in diabetic population and reduction in treatment cost will also trigger the growth of this market. Many complicated medical conditions and illnesses can be treated with these infusion therapies which will reduce the hospital stay, and hence reduce the cost of treatment as well. Home infusion therapies are safer since the administration of the drugs is observed by physicians. This will also augment the growth of this market. Reimbursement policies of various public and private firms will also boost the growth of this market.

Forthcoming Projections for the Market of Home Infusion Therapy: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1702


Despite all these, sometimes overdosage of medications may cause hazardous conditions which may hinder the growth of this market. The major players operating in this market include Abbott Laboratories, Stryker Corporation, Continuum Rx, Bristol-Myers Squibb, and Eli Lilly and Company, among other significant players.

No comments:

Post a Comment